【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in incidence of cancer across the globe
3.5.1.2. Increase in government expenditure on healthcare
3.5.1.3. Surge in awareness regarding immunotherapy
3.5.2. Restraints
3.5.2.1. High cost of cancer immunotherapy treatment
3.5.2.2. Stringent government regulations toward approval of immunotherapy
3.5.3. Opportunity
3.5.3.1. Surge in R&D activities toward the development of immunotherapy
3.6. Government regulatory scenerio
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.6.4. Thailand
3.6.5. Singapore
3.6.6. Malaysia
3.6.7. Mexico
3.6.8. Australia
CHAPTER 4: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY THERAPEUTICS
4.1. Overview
4.1.1. Market and forecast
4.2. Natural killer cell therapies
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.3.1. CNDO-109
4.2.3.2. oNKord
4.2.3.3. Natural Killer Cells
4.2.3.4. Others
4.3. NK cell-directed antibodies
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.3.1. MOGAMULIZUMAB
4.3.3.2. Lirilumab
4.3.3.3. AFM13
4.3.3.4. NKTT 120
4.3.3.5. Others
CHAPTER 5: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by region
5.2. Cancer
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Gastrointestinal diseases
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Immunoproliferative disorders
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY END USER
6.1. Overview
6.1.1. Market and forecast
6.2. Research centers and institutes
6.2.1. Market and forecast, by region
6.2.2. Market analysis, by country
6.3. Hospitals and clinics
6.3.1. Market and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: NATURAL KILLER CELL THERAPEUTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by therapeutics
7.2.3. Market size and forecast, by application
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by therapeutics
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by therapeutics
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by end user
7.2.5.7. Mexico market size and forecast, by therapeutics
7.2.5.8. Mexico market size and forecast, by application
7.2.5.9. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by therapeutics
7.3.3. Market size and forecast, by application
7.3.4. Market size and forecast, by end user
7.3.5. Market size and forecast, by country
7.3.5.1. UK market size and forecast, by therapeutics
7.3.5.2. UK market size and forecast, by application
7.3.5.3. UK market size and forecast, by end user
7.3.5.4. Germany market size and forecast, by therapeutics
7.3.5.5. Germany market size and forecast, by application
7.3.5.6. Germany market size and forecast, by end user
7.3.5.7. France market size and forecast, by therapeutics
7.3.5.8. France market size and forecast, by application
7.3.5.9. France market size and forecast, by end user
7.3.5.10. Italy market size and forecast, by therapeutics
7.3.5.11. Italy market size and forecast, by application
7.3.5.12. Italy market size and forecast, by end user
7.3.5.13. Spain market size and forecast, by therapeutics
7.3.5.14. Spain market size and forecast, by application
7.3.5.15. Spain market size and forecast, by end user
7.3.5.16. Rest of Europe market size and forecast, by therapeutics
7.3.5.17. Rest of Europe market size and forecast, by application
7.3.5.18. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by therapeutics
7.4.3. Market size and forecast, by application
7.4.4. Market size and forecast, by end user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan market size and forecast, by therapeutics
7.4.5.2. Japan market size and forecast, by application
7.4.5.3. Japan market size and forecast, by end user
7.4.5.4. China market size and forecast, by therapeutics
7.4.5.5. China market size and forecast, by application
7.4.5.6. China market size and forecast, by end user
7.4.5.7. Australia market size and forecast, by therapeutics
7.4.5.8. Australia market size and forecast, by application
7.4.5.9. Australia market size and forecast, by end user
7.4.5.10. India market size and forecast, by therapeutics
7.4.5.11. India market size and forecast, by application
7.4.5.12. India market size and forecast, by end user
7.4.5.13. Rest of Asia-Pacific market size and forecast, by therapeutics
7.4.5.14. Rest of Asia-Pacific market size and forecast, by application
7.4.5.15. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by therapeutics
7.5.3. Market size and forecast, by application
7.5.4. Market size and forecast, by end user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by therapeutics
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. Saudi Arabia market size and forecast, by therapeutics
7.5.5.5. Saudi Arabia market size and forecast, by application
7.5.5.6. Saudi Arabia market size and forecast, by end user
7.5.5.7. South Africa market size and forecast, by therapeutics
7.5.5.8. South Africa market size and forecast, by application
7.5.5.9. South Africa market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by therapeutics
7.5.5.11. Rest of LAMEA market size and forecast, by application
7.5.5.12. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. AFFIMED N.V.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. CELGENE CORPORATION
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. FATE THERAPEUTICS INC.
8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Product portfolio
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. FORTRESS BIOTECH
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.5. GLYCOSTEM THERAPEUTICS BV
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Key strategic moves and developments
8.6. INNATE PHARMA SA
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. NANTKWEST INC
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. NKARTA THERAPEUTICS, INC.
8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NKT THERAPEUTICS INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.10. ZIOPHARM ONCOLOGY INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
【レポート販売概要】
■ タイトル：ナチュラルキラー細胞治療法の世界市場：NK細胞療法、NK細胞向け抗体■ 英文：Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2026
■ 発行日：2019年7月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9NV088
■ 調査対象地域：グローバル
- 世界における小型自動車用点火装置及びプラグ市場（2008-2028）This latest just-auto report edition offers a global review of the OE ignition systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE ignition systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies a …
- 日本の気道装置・麻酔装置市場Japan Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "Japan Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the Japan Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, Anesthesia Masks, Ai …
- 世界のEOR（石油増進回収法）年鑑2015：地層内回収オイルサンドEOR、重油EOR、CO2圧入攻法EORIf you are involved with Enhanced Oil Recovery (EOR), you must have this definitive reference guide. This brand new 532 page yearbook from business intelligence provider visiongain compiles visiongain’s extensive database of EOR projects and industry knowledge of chemical, gas & thermal EOR into one comprehensive document. Visiongain has calculated that global EOR spending will reach $26.2bn in 20 …
- 世界の食品安全性検査・診断市場予測：サルモネラ菌、リステリア菌、大腸菌、GMO、毒素、農薬検査などThe world market for the Food Safety Testing & Diagnostics will reach $11.03bn in 2014. Quality and safety testing of food is an area of growing importance, where accurate analytical results are critical, be that for exporters, importers or government bodies. With rising globalisation levels, standardisation of food safety testing methods across the world becomes paramount to all food industry pla …
- 動物用ワクチンの世界市場予測（～2022年）：種類、疾患、技術別分析“Veterinary Vaccines market is projected to register a CAGR of 5.9%”The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of 5.9% during the forecast period. Market growth can be attributed to factors such as growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; …
- Daybreak Oil and Gas, Inc.：石油・ガスの開発・生産動向及びコスト分析- 2012Daybreak Oil and Gas, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Daybreak Oil and Gas, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- パワーエレクトロニクスの世界市場分析：材料別（シリコン、サファイア、SiC、GaN系、およびその他）、機器別（ディスクリート、モジュール、IC）、用途別（ICT、家庭用電化製品、電力、産業、自動車、航空宇宙・防衛）、セグメント予測、2014-2025The global power electronics market is expected to reach USD 39.22 billion by 2025, according to a new report by Grand View Research, Inc. Increased focus on the usage of renewable energy sources has been one of the major factors driving the market. In addition, the development of power infrastructure, coupled with the increasing demand for battery-powered portable devices, has led to the increase …
- ポリエチレンテレフタラート(PET)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world polyethylene terephthalate market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together gi …
- 自動車用ワイパーモーターアフターマーケットの世界市場予測（～2021年）The wiper motor aftermarket is projected to grow from USD 2.31 billion in 2016 to USD 2.65 billion by 2021, at a CAGR of 2.78% during the forecast period. The wiper motor aftermarket is primarily driven by two important factors, one is the usage of wiper system, and the other is the increasing number of vehicles on road. The wiper motor is a critical component that drives the wiper system. The veh …
- Familial Chylomicronemia (Type I Hyperlipoproteinemia)：治療薬のグローバル治験動向（2014年上半期）Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014" provides data on the Familial Chylomicronemia (Type I Hyperlipoproteinemia) clinical trial scenario. This report provides elemental information and data relating to …
- プレバイオティクス成分の世界市場：オリゴ糖、イヌリン、ポリデキストロースThe global demand for dairy products is on the rise. Rise in disposable incomes, changing lifestyles, and increasing health awareness are the main reasons for the increasing demand for food & beverage products. The growing concerns for sugar and fat free products resulted in an increased consumption in the processed food industry. This growing demand for diary products has resulted in an increased …
- 世界における小型自動車用OE(メーカー純正部品)排気装置市場（2008-2028）This latest just-auto report edition offers a global review of the OE automotive exhaust systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE exhaust systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their str …
- ヘルニア修復の世界市場予測（～2023年）“The hernia repair market projected to grow at a CAGR of 3.0% from 2018 to 2023.” The hernia repair market is projected to reach USD 4.75 billion by 2023 from USD 4.09 billion in 2018, at a CAGR of 3.0%. Factors such as the increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and favorable reimbursement scenario in developed countries are d …
- 自動トラック積載装置の世界市場About Automated Truck Loading SystemAutomated truck loading systems (ATLS) are used to load trucks and trailers and are used to ensure material handling operations are faster, safer, and have low operational costs. An ATLS comprises two components: the trailer system in the truck trailer and the dock system in the loading ramp. They are majorly used for one-way loading and shuttle transportation. …
- アルファ-マンノシドーシス（Alpha-Mannosidosis）：グローバル臨床試験レビュー（2014年上半期）Alpha-Mannosidosis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Alpha-Mannosidosis Global Clinical Trials Review, H1, 2014" provides data on the Alpha-Mannosidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha-Mannosidosis. It includes an overview of the trial numbers and their recruitme …
